ClinicalTrials.Veeva

Menu

Optical Coherence Tomography of Airway and Pleural Disorders

University of California Irvine (UCI) logo

University of California Irvine (UCI)

Status

Withdrawn

Conditions

Disorder of Pleura and Pleural Cavity

Treatments

Device: Optical Coherence Tomography imaging

Study type

Observational

Funder types

Other

Identifiers

NCT00580892
20064982

Details and patient eligibility

About

The researcher can use Optical coherence tomography a near-infrared diode to emit light that can produce images of the specimen under investigation and provide information about tissue abnormalities without causing damage.

Full description

The researcher can use Optical coherence tomography endoscopic imaging to improve diagnosis and treatment of airway and pleural malignancy. In the events of burn injury and smoke inhalation injury, the Optical coherence tomography can determine the change of the airway tissues and severity of airway injury.

During endoscopic procedure the lesions will be biopsied and prepared by standard histologic methods. The Optical coherence tomography endoscopic imaging can measured histologic of the tissue samples and compared to standard histologic examination. The Optical coherence tomography endoscopic imaging can measured the epithelial thickness and compared to visual inspection of the mucosa on bronchoscopy.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult 18 or older, male or female.
  • Plans for bronchoscopic with possible biopsy procedures.

Exclusion criteria

  • Age less than 18 years of age
  • Not plan for bronchoscopic with possible biopsy procedures.
  • Pregnant or breastfeeding.

Trial design

0 participants in 1 patient group

Airway and Pleural Disorders
Description:
Optical Coherence Tomography imaging
Treatment:
Device: Optical Coherence Tomography imaging

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems